Literature DB >> 1185850

Molecular structure of human fibroblast and leukocyte interferons: probe by lectin and hydrophobic chromatography.

W J Jankowski, M W Davey, J A O'Malley, E Sulkowski, W A Carter.   

Abstract

Structural differences between human leukocyte virus-induced interferon and human fibroblast polyinosinic-polycytidylic acid (rIn-rCn)-induced interferon have been noted in previous studies. This study reports the behavior of human leukocyte and fibroblast interferon, induced by virus and by rIn-rCn, in several lectin and hydrophobic chromatographic systems. Differences in both glycosylation and in hydrophobicity of human leukocyte and fibroblast interferons are documented. Human fibroblast interferon is a glycoprotein, whereas our evidence suggests that human leukocyte interferon probably is not. Also, fibroblast interferon is more hydrophobic than leukocyte interferon, as probed on several hydrophobic adsorbents. The possible relationships of these differences to each other and to antigenic variations are discussed. Generally, the differences appear to be attributable to the cell type in which the interferon was induced. However, our results suggest that at least subtle differences in the processing of the induction signal (virus or rIn-rCn) within the same cell type may occur, slightly altering some structural features.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1185850      PMCID: PMC355710     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  13 in total

1.  Suppression of human interferon production by inhibitors of glycosylation.

Authors:  E A Havell; J Vilcek; E Falcoff; B Berman
Journal:  Virology       Date:  1975-02       Impact factor: 3.616

2.  Selective binding of human interferon to albumin immoblized on agarose.

Authors:  J W Huang; M W Davey; C J Hejna; W Von Muenchhausen; E Sulkowski; W A Carter
Journal:  J Biol Chem       Date:  1974-07-25       Impact factor: 5.157

3.  No evidence for a carbohydrate moiety affecting the clearance of circulating human leukocyte interferon in rabbits.

Authors:  K E Mogensen; L Pyhälä; E Törmä; K Cantell
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

4.  Hydrophobic interaction of human interferon with concanavalin A-agarose.

Authors:  M W Davey; J W Huang; E Sulkowski; W A Carter
Journal:  J Biol Chem       Date:  1974-10-10       Impact factor: 5.157

5.  [Human interferons induced in vitro by synthetic polynucleotides].

Authors:  E Falcoff; R Perez-Bercoff
Journal:  Biochim Biophys Acta       Date:  1969-01-21

6.  Molecular basis of the action of interferon.

Authors:  H B Levy; W A Carter
Journal:  J Mol Biol       Date:  1968-02-14       Impact factor: 5.469

7.  Production of high-titered interferon in cultures of human diploid cells.

Authors:  E A Havell; J Vilcek
Journal:  Antimicrob Agents Chemother       Date:  1972-12       Impact factor: 5.191

8.  Purification of a hemagglutinin from Limulus polyphemus by affinity chromatography.

Authors:  J D Oppenheim; M S Nachbar; M R Salton; F Aull
Journal:  Biochem Biophys Res Commun       Date:  1974-06-18       Impact factor: 3.575

9.  Partial purification of human interferon by affinity chromatography.

Authors:  C B Anfinsen; S Bose; L Corley; D Gurari-Rotman
Journal:  Proc Natl Acad Sci U S A       Date:  1974-08       Impact factor: 11.205

10.  Two antigenically distinct species of human interferon.

Authors:  E A Havell; B Berman; C A Ogburn; K Berg; K Paucker; J Vilcek
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

View more
  20 in total

1.  Elimination of size and charge heterogeneities of human leukocyte interferons by chemical cleavage.

Authors:  W E Stewart; L S Lin; M Wiranowska-Stewart; K Cantell
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

2.  Stable and unstable forms of human fibroblast interferon.

Authors:  V G Edy; J Desmyter; A Billiau; P De Somer
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

3.  Differences in mouse interferons according to cell source and mode of induction.

Authors:  N Maehara; M Ho; J A Armstrong
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

Review 4.  Interferons: anti-neoplastic drugs?

Authors:  H Strander
Journal:  Blut       Date:  1977-09-18

5.  Glycosylation of human leukocyte interferon: effects of tunicamycin.

Authors:  K C Chadha; P M Grob; R L Hamill; E Sulkowski
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

6.  Enzymatic modifications of human fibroblast and leukocyte interferons.

Authors:  M J Otto; J J Sedmak; S E Grossberg
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

Review 7.  Differences between human alpha (leukocyte) and beta (fibroblast) interferons.

Authors:  T G Hayes
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

8.  Properties of bovine interferons.

Authors:  V E Luna; A D Luk; S K Tyring; J M Hellman; S S Lefkowitz
Journal:  Experientia       Date:  1984-12-15

9.  Affinity chromatography of primary human amnion interferon.

Authors:  P C Ferreira; M Paucker; R R Golgher; K Paucker
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

10.  Evidence for a unique human fibroblast interferon (IFN-beta 1) chromosomal gene, devoid of intervening sequences.

Authors:  J Tavernier; R Derynck; W Fiers
Journal:  Nucleic Acids Res       Date:  1981-02-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.